Results 221 to 230 of about 19,552 (331)

Longitudinal Associations of Serum Orexin‐A With Physical Activity and Sleep in Schizophrenia: A Preliminary Study

Neuropsychopharmacology Reports, Volume 45, Issue 4, December 2025.
In this longitudinal study of schizophrenia, increases in serum orexin‐A were associated with greater daytime activity and reduced time in bed, indicating that orexinergic signaling may influence behavioral activation beyond sleep–wake regulation and could serve as a biomarker or therapeutic target.
Akira Tanaka, Yusuke Arai, Takehiko Yasaki, Kentaro Saito, Erika Nakashizuka, Shinsuke Yoshida, Yuka Nakajima, Mika Koido, Kazuhiro Suzuki, Toshinori Nakamura, Daimei Sasayama, Shinsuke Washizuka   +11 more
wiley   +1 more source

Central Nervous System-Active Medications and Risk of Hospital Readmission in Older Multimorbid Adults. [PDF]

J Am Geriatr Soc
Stuber MJ, Brockhus LA, Spinewine A, O'Mahony D, Jennings E, Dalleur O, Knol W, Koek HL, Baggio S, Rodondi N, Aubert CE.   +10 more
europepmc   +1 more source

TRENDS OF SEDATIVE-HYPNOTICS CONSUMPTION AMONGST THE MEDICAL STUDENT POPULATION OF MULTAN

Noaman Ishaq, Nausheen Ata, Hina Fatima, Mahwish Gul, Saba Batool, Maryam Saqib   +5 more
openalex   +2 more sources

Delivering Care Consistent With the Psychosocial Standards—Provider Report: Implementing the Standards Together—Engaging Parents and Providers in Psychosocial Care (iSTEPPP) Study

Pediatric Blood &Cancer, Volume 72, Issue 12, December 2025.
ABSTRACT Background Evidence‐based Standards for Psychosocial Care for Children with Cancer and their Families were published in 2015. Determining how often care delivery practices and approaches align with the Standards is important for understanding the reach of the Standards. Procedure Medical (n = 73) and psychosocial (n = 99) providers from 129 of
Anne E. Kazak, Michele A. Scialla, Kimberly S. Canter, Victoria Sardi‐Brown, Kimberly Buff, Kamyar Arasteh, Emily Pariseau, Eric Sandler, Lori Wiener   +8 more
wiley   +1 more source

How does psychoactive substance use affect health students? An important local cutout. [PDF]

Brain Behav Immun Health
Sampaio GR, Silva MBL, Soares DM, Braga-de-Souza S.   +3 more
europepmc   +1 more source

Sedative and hypnotic effects of Iranian traditional medicinal herbs used for treatment of insomnia

, 2011
Sasan Andalib, Ali Vaseghi, Golnaz Vaseghi, Azadeh Motavallian   +3 more
openalex   +2 more sources

Factors associated with treatment failure after discharge in inpatients with schizophrenia spectrum disorders: A retrospective observational study

Psychiatry and Clinical Neurosciences Reports, Volume 4, Issue 4, December 2025.
Abstract Aim Schizophrenia spectrum disorders are among the most serious mental illnesses that cause social dysfunction. Patients with schizophrenia spectrum disorders are prone to recurrence, and those who require hospitalization are at a high risk; hence, preventing treatment failure after discharge is essential.
Yoshitaka Saito, Hiroyuki Muraoka, Takayuki Yokoyama, Katsuichiro Shimizu, Yukihiro Tanno, Nagomi Kida, Taiyo Nishikawa, Shin Miyake, Yukio Kenmotsu, Kosei Kamimura, Hirohito Kato, Yuka Noguchi, Seita Tsuchida, Ryutaro Suzuki, Yuki Yoshimura, Shoko Miura, Shunsuke Kamitani, Takaaki Hirooka, Enami Sawayama, Satoru Oishi, Ken Inada   +20 more
wiley   +1 more source

Association between higher cerebrospinal fluid levels of phosphorylated tau and reduced depressive symptoms in patients with cognitive decline

Psychiatry and Clinical Neurosciences Reports, Volume 4, Issue 4, December 2025.
Abstract Aim In individuals with cognitive decline, depressive symptoms can affect disease progression and quality of life. One factor that may be associated with depressive symptoms is phosphorylated tau (p‐tau). However, the association between p‐tau and depressive symptoms remains controversial.
Takashi Ozaki, Naoki Hashimoto, Hisashi Narita, Niki Udo, Shizuka Mito, Shin Nakagawa, Ichiro Kusumi, Takahiro A. Kato   +7 more
wiley   +1 more source

Off-label use of psychotropic drugs in youth. [PDF]

BMC Psychiatry
Rosland HG, Wergeland GJ, Holst L.
europepmc   +1 more source

Efficacy of lurasidone on anxiety symptoms in patients with schizophrenia: A pooled post hoc analysis of five randomized, placebo‐controlled trials

Psychiatry and Clinical Neurosciences Reports, Volume 4, Issue 4, December 2025.
Abstract Aim Comorbid anxiety disorders and their symptoms are common in schizophrenia and may occur before a relapse. The aim of this post hoc analysis is to investigate the efficacy of lurasidone on comorbid anxiety symptoms in patients with schizophrenia.
Takahiro Nemoto, Miyuki Okumura, Hidenori Maruyama   +2 more
wiley   +1 more source